Search research articles
Contact Us
Filters
Showing results (51-60 of 111) with videos related to
Page
of 12
Sort By:
Cancer Research
|
July 9, 1999
Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity
Y Cai, M H Wu, S M Ludeman, et al.
Carcinogenesis
|
April 1, 1993
The role of O6-alkylguanine-DNA alkyltransferase in protecting Rat4 cells against the mutagenic effects of O6-substituted guanine residues incorporated in codon 12 of the H-ras gene
R E Bishop, L L Dunn, G T Pauly, et al.
Carcinogenesis
|
September 1, 1991
Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine
A E Pegg, L Wiest, C Mummert, et al.
Chemical Research in Toxicology
|
November 1, 1994
Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley rats
D M Kokkinakis, R C Moschel, A E Pegg, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer
M E Dolan, A E Pegg, N D Biser, et al.
Carcinogenesis
|
December 1, 1991
Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine
M E Dolan, A E Pegg, L L Dumenco, et al.
Biochemical Pharmacology
|
October 26, 1995
Human liver oxidative metabolism of O6-benzylguanine
S K Roy, K R Korzekwa, F J Gonzalez, et al.
Gene Therapy
|
April 21, 2001
Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation
M H Wu, D N Liebowitz, S L Smith, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice
R B Ewesuedo, L R Wilson, H S Friedman, et al.
Cancer Chemotherapy and Pharmacology
|
August 13, 2002
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer
D K Park, C W Ryan, M E Dolan, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 111) with videos related to
Sort By:
Page
of 12
Cancer Research
|
July 9, 1999
Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity
Y Cai, M H Wu, S M Ludeman, et al.
Carcinogenesis
|
April 1, 1993
The role of O6-alkylguanine-DNA alkyltransferase in protecting Rat4 cells against the mutagenic effects of O6-substituted guanine residues incorporated in codon 12 of the H-ras gene
R E Bishop, L L Dunn, G T Pauly, et al.
Carcinogenesis
|
September 1, 1991
Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine
A E Pegg, L Wiest, C Mummert, et al.
Chemical Research in Toxicology
|
November 1, 1994
Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley rats
D M Kokkinakis, R C Moschel, A E Pegg, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Effect of O6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer
M E Dolan, A E Pegg, N D Biser, et al.
Carcinogenesis
|
December 1, 1991
Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine
M E Dolan, A E Pegg, L L Dumenco, et al.
Biochemical Pharmacology
|
October 26, 1995
Human liver oxidative metabolism of O6-benzylguanine
S K Roy, K R Korzekwa, F J Gonzalez, et al.
Gene Therapy
|
April 21, 2001
Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation
M H Wu, D N Liebowitz, S L Smith, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice
R B Ewesuedo, L R Wilson, H S Friedman, et al.
Cancer Chemotherapy and Pharmacology
|
August 13, 2002
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer
D K Park, C W Ryan, M E Dolan, et al.
Page
of 12